Histiocytosis

6 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Narrower: Erdheim-Chester Disease 2

Treatments and conditions

Histiocytosis
Treatment and conditionWhere it standsTrials
FOLFIRI + FOLFOX6/FOLFOX7 + S241656 + PANITUMUMAB + Cetuximab for histiocytosisPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Lenalidomide for erdheim-chester diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
S241656 for histiocytosisPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
S241656 + PEMBROLIZUMAB for histiocytosisPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
S241656 + Trametinib for histiocytosisPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Trametinib + DABRAFENIB for erdheim-chester diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.